Coronavirus update for Monday, June 1 as of 3:00 pm.

Department of Health and Human Services

  • HHS has added to and modified its CARES Act Provider Relief Fund FAQ.  Find additions on pages 2, 4, 5, 8, 23, 24, and 25 and modifications on pages 8, 9, and 19.  The latest changes are identified as added or modified on 5/26 or 5/29.  Providers should review these changes carefully.

Centers for Medicare & Medicaid Services

Centers for Medicare & Medicaid Services – Stakeholder Calls

CMS hosts recurring stakeholder engagement sessions to share information related to the agency’s response to COVID-19.  These sessions are open to members of the health care community and are intended to provide updates, share best practices among peers, and offer attendees an opportunity to ask questions of CMS and other subject matter experts.  Call details are below.  Conference lines are limited so CMS encourages interested parties to join via audio webcast.  Calls recordings and transcripts also are posted on the CMS podcast page here.

CMS COVID-19 Office Hours Calls (Tuesdays at 5:00 – 6:00 PM eastern)

Office Hour Calls provide an opportunity for hospitals, health systems, and providers to ask questions of agency officials regarding CMS’s temporary actions that empower local hospitals and healthcare systems to increase hospital capacity, expand their health care workforce, and promote greater use of telehealth in Medicare.

Toll Free Attendee Dial In: 833-614-0820; Access Passcode: 4474407

Audio Webcast link:  go here.

Lessons from the Front Lines: COVID-19 (Fridays at 12:30 – 2:00 PM eastern)

Lessons from the Front Lines calls are a joint effort between CMS Administrator Seema Verma, FDA Commissioner Stephen Hahn, MD, and the White House Coronavirus Task Force.  Physicians and other clinicians are invited to share their experience, ideas, strategies, and insights with one another related to their COVID-19 response. There is an opportunity to ask questions of presenters.

Toll Free Attendee Dial-In: 833-614-0820; Access Code: 6583696

Web Link:  go here.

Centers for Disease Control and Prevention

Food and Drug Administration

  • The FDA is making its previously developed FDA MyStudies app available to investigators as a free platform to securely obtain patients’ informed consent for eligible clinical trials when face-to-face contact is not possible or practical due to COVID-19 control measures. FDA MyStudies is now referred to as COVID MyStudies in the Apple App store and in the Google Play store.
  • The FDA has approved emergency use authorization for a new commercial home diagnostic test for COVID-19.
  • The FDA has approved emergency use authorizations for three new commercial laboratory serology tests for COVID-19. Find those authorizations here, here, and here.

Federal Funding Opportunities for Hospitals

  • NASH has prepared a document that collects and presents in one place the various new federal funding opportunities for hospital resulting from legislation addressing the COVID-19 public health emergency.  Find that document here.

(To receive this daily update directly, sign up for our mailing list at